Corporate news

Revenues up 1.4% to EUR 301.8m (organic growth -2.4%) Adjusted EBITDA growth of 7.2% to EUR 51.0m (Q1 2014: EUR 47.6m) Net income climbs 22.8% to…

Revenues up 1.9% (3.7% organically) to EUR 1,290.0m Adjusted EBITDA totals EUR 258.5m at constant exchange rates Earnings per share up 6.6% to…

Düsseldorf/Dongguan City (People’s Republic of China), October 22, 2014 – Gerresheimer AG, an internationally leading partner to the pharma and…

Gerresheimer sees good growth opportunities in long-term megatrends of pharma and healthcare Growing importance of drug delivery and dosage devices…

Revenues up 2.2% to EUR 323.9m (+3.2% at constant exchange rates) Adjusted EBITDA with slight improvement on prior-year quarter at EUR 62.1m Net…

Revenues up 2.6% to EUR 335.4m (6.0% at constant exchange rates) Adjusted EBITDA rises 9.1% to EUR 65.1m (14.1% at constant exchange rates) Net…

Dividend raised to EUR 0.70 per share Management Board and Supervisory Board given formal approval by large majority Dr. Axel Herberg new member…

Düsseldorf/Peachtree City (Georgia/USA), March 10, 2014 – Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry,…

Third-quarter revenues up 1.8% (+4.5% excluding exchange rate effects), to EUR 316.9m Adjusted EBITDA reaches EUR 61.6m (prior-year quarter: EUR…